Arthex Biotech Appoints Frédéric Legros, Ph.D., as Executive Chairman of the Board

VALENCIA, Spain, Nov. 28, 2022 /PRNewswire/ — Arthex Biotech S.A., a pre-clinical stage biotechnology company pioneering innovative microRNA modulating approaches to diseases with high unmet medical needs, today announced that Frédéric Legros, PhD, has joined the Company’s Board of…